Tag : Palsy

Latest News

Incidence of Bell’s Palsy in 28 Major Markets 2019-2029: Some of these Markets are US, Canada, UK, Brazil, Japan, China, Australia & South Korea – ResearchAndMarkets.com

Newsemia
DUBLIN–(BUSINESS WIRE)–The “Incidence of Bell’s Palsy in 28 Major Markets 2019-2029” report has been added to ResearchAndMarkets.com’s offering. Bell’s palsy, also known as idiopathic facial...
Neurology

The Falls and Frustrations of Progressive Supranuclear Palsy

Newsemia
PSP is a rare neurogenerative disorder that is increasingly appreciated among neurologists. Yet effective treatments remain elusive. Medscape Neurology Source link...
Neurology

Combining quantitative susceptibility mapping to the morphometric index in differentiating between progressive supranuclear palsy and Parkinson's disease

Newsemia
To determine whether the susceptibility value in the deep gray matter obtained by quantitative susceptibility mapping (QSM) provides additive value to the morphometric index for...
Neurology

Adults with cerebral palsy twice as likely to develop cardiovascular, chronic respiratory diseases

Newsemia
Adults with cerebral palsy are about twice as likely to develop cardiovascular disease and chronic respiratory disease compared to adults without cerebral palsy, according to...
Latest News

The genetic and clinico-pathological profile of early-onset progressive supranuclear palsy

Newsemia
Jabbari, E; Woodside, J; Tan, MMX; Pavese, N; Bandmann, O; Ghosh, BCP; Massey, LA; … Morris, HR; + view all Jabbari, E; Woodside, J; Tan,...
Neurology

Safety of the tau-directed monoclonal antibody BIIB092 in progressive supranuclear palsy: a randomised, placebo-controlled, multiple ascending dose phase 1b trial

Newsemia
Congratulations Dr. Nikolaus McFarland on the publication of “Safety of the tau-directed monoclonal antibody BIIB092 in progressive supranuclear palsy: a randomised, placebo-controlled, multiple ascending dose...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy